NCT07143669 2026-03-31
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
Recruiting
Blueprint Medicines Corporation
OHSU Knight Cancer Institute
Instituto Nacional de Cancerologia de Mexico
Massachusetts General Hospital
University of Pretoria
Dana-Farber Cancer Institute
Centre Hospitalier Intercommunal Creteil